Development and validation of a multiplex add-on assay for sepsis biomarkers using xMAP technology.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Clinical Chemistry

• Publication date

  2006-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1373/CLINCHEM.2006.067595PMID 16690735
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical laboratory differentiation of infectious versus non-infectious systemic inflammatory response syndrome.

  2005cited by this paper
• Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology.

  2005cited by this paper
• MACROPHAGE MIGRATION INHIBITORY FACTOR IS ASSOCIATED WITH POSITIVE CULTURES IN PATIENTS WITH SEPSIS AFTER CARDIAC SURGERY

  2005cited by this paper
• Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology.

  2005influential reference
• Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer

  2005cited by this paper
• Development, validation, and implementation of a multiplex immunoassay for the simultaneous determination of five cytokines in human serum.

  2005cited by this paper
• Validation and comparison of luminex multiplex cytokine analysis kits with ELISA: determinations of a panel of nine cytokines in clinical sample culture supernatants.

  2005cited by this paper
• Biomarkers of sepsis: clinically useful?

  2005cited by this paper
• Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system.

  2005cited by this paper
• Does soluble triggering receptor expressed on myeloid cells‐1 play any role in the pathogenesis of septic shock?

  2005cited by this paper
• Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia

  2005cited by this paper
• Multiplex bead array assays for detection of soluble cytokines: Comparisons of sensitivity and quantitative values among kits from multiple manufacturers

  2004cited by this paper
• Toward resolving the challenges of sepsis diagnosis.

  2004cited by this paper
• MACROPHAGE MIGRATION INHIBITORY FACTOR LEVELS CORRELATE WITH FATAL OUTCOME IN SEPSIS

  2004cited by this paper
• Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis

  2004cited by this paper
• Soluble urokinase receptor is elevated in cerebrospinal fluid from patients with purulent meningitis and is associated with fatal outcome

  2004cited by this paper
• Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia.

  2004cited by this paper
• Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection

  2004cited by this paper
• The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality.

  2004cited by this paper
• Bioanalytical Method Validation

  2004cited by this paper
• TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

  2003cited by this paper
• Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear Cells

  2003cited by this paper
• The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau.

  2002cited by this paper
• Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay.

  2002cited by this paper
• TREM-1 amplifies inflammation and is a crucial mediator of septic shock

  2001cited by this paper
• Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling

  2001cited by this paper
• Increased Stability of Macrophage Migration Inhibitory Factor (MIF) in DU-145 Prostate Cancer Cells

  2000cited by this paper
• Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection.

  2000cited by this paper
• Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1

  2000cited by this paper
• Immunoassays for detecting cytokines: what are they really measuring?

  1995cited by this paper
• Migration inhibitory factor-binding sarcolectin from human placenta is indistinguishable from a subfraction of human serum albumin.

  1994cited by this paper
• Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome

  1993cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Clinical Chemistry

  1884cited by this paper

• suPAR as a biomarker of support in different clinical settings.

  2025cites this paper
• Influence of Protein Glycosylation on the Measurement of Soluble Urokinase Plasminogen Activator Receptor.

  2025cites this paper
• SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19

  2024cites this paper
• Multiplex Detection of SNPs for Genetic Monitoring in Laboratory Mice by Luminex xTAG Assay

  2024cites this paper
• suPAR in cardiovascular disease.

  2024cites this paper
• Sepsis biomarkers for early diagnosis of bacteremia in emergency department.

  2023cites this paper
• SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

  2023cites this paper
• Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis

  2022cites this paper
• Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test

  2022cites this paper
• Photoswitch-Based Fluorescence Encoding of Microspheres in a Limited Spectral Window for Multiplexed Detection.

  2022cites this paper
• Comparison of Aptamer-Based and Antibody-Based Assays for Protein Quantification in Chronic Kidney Disease

  2022cites this paper
• Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials

  2021cites this paper
• Antibody Arrays: Methods and Protocols

  2021cites this paper
• Dried Blood-Based Protein Profiling Using Antibody Arrays.

  2021cites this paper
• Association of soluble urokinase plasminogen activator receptor levels with fibrotic and vascular manifestations in systemic sclerosis

  2021cites this paper
• Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

  2021cites this paper
• Increased sTREM-1 levels identify cirrhotic patients with bacterial infection and predict their 90-day mortality.

  2021cites this paper
• Combined suPAR and qSOFA for the prediction of 28-day mortality in sepsis patients

  2021cites this paper
• Dried blood sample analysis by antibody array across the total testing process

  2021cites this paper
• Trends in Multiplex Immunoassays for In Vitro Diagnostics and Point-of-Care Testing

  2021cites this paper
• Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery

  2021cites this paper
• Variability in CKD Biomarker Studies: Soluble Urokinase Plasminogen Activator Receptor (suPAR) and Kidney Disease Progression in the Chronic Kidney Disease in Children (CKiD) Study

  2021cites this paper
• Combined SuPAR and qSOFA for predicting 28-day mortality in sepsis

  2021cites this paper
• Prognostic value of inflammatory markers for detecting anastomotic leakage after esophageal resection

  2020cites this paper
• Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.

  2020cites this paper
• Urinary suPAR: a non-invasive biomarker of infection and tissue inflammation for use in studies of large free-ranging mammals

  2020cites this paper
• Cardio‐Renal Biomarker Soluble Urokinase‐Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C‐Reactive Protein, and Renal Function

  2020cites this paper
• Association between sepsis at ICU admission and mortality in patients with ICU-acquired pneumonia: An infectious second-hit model.

  2020cites this paper
• Prognostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor and High-Sensitivity C-Reactive Protein on Postoperative Mortality in Patients Undergoing Elective On-Pump Cardiac Surgery.

  2020cites this paper
• Evaluation of the host cytokine response in dogs with sepsis and noninfectious systemic inflammatory response syndrome.

  2019cites this paper
• Analytical, biochemical and clearance considerations of soluble urokinase plasminogen activator receptor (suPAR) in healthy individuals.

  2019cites this paper
• The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine

  2019cites this paper
• Multiplex Immunoassays

  2019cites this paper
• Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes

  2019cites this paper
• Bronchoalveolar fluid and plasma inflammatory biomarkers in contemporary ARDS patients

  2019cites this paper
• An in vitro model mimics the contact of biomaterials to blood components and the reaction of surrounding soft tissue.

  2019cites this paper
• Healthy lifestyles reduce suPAR and mortality in a Danish general population study

  2019cites this paper
• Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.

  2019cites this paper
• Soluble urokinase‐type plasminogen activator receptor is associated with signs of periodontitis in adolescents

  2018cites this paper
• Simultaneous Immunodetection of Anthrax, Plague, and Tularemia from Blood Cultures by Use of Multiplexed Suspension Arrays

  2018cites this paper
• Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD

  2018cites this paper
• Immune therapy in sepsis: Are we ready to try again?

  2018cites this paper
• Inflammation and post-operative recovery in patients undergoing total knee arthroplasty-secondary analysis of a randomized controlled trial.

  2017cites this paper
• Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis

  2017cites this paper
• Soluble urokinase‐type plasminogen activator receptor (suPAR) and interleukin‐6 levels in hyperemesis gravidarum

  2017cites this paper
• Work ability assessment among acutely admitted patients using biomarkers

  2017cites this paper
• Nature and Clonality of the Fluoresceinated Secondary Antibody in Luminex Multiplex Bead Assays Are Critical Factors for Reliable Monitoring of Serum HLA Antibody Levels in Patients for Donor Organ Selection, Desensitization Therapy, and Assessment of the Risk for Graft Loss

  2017cites this paper
• Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.

  2017cites this paper
• Plasma Level of Soluble Urokinase-type Plasminogen Activator Receptor Predicts the Severity of Acute Alcohol Pancreatitis

  2017cites this paper
• Toll-like receptor 9 modifies intestinal serotonergic system.

  2016cites this paper
• Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study

  2016cites this paper
• suPAR level is associated with myocardial impairment assessed with advanced echocardiography in patients with type 1 diabetes with normal ejection fraction and without known heart disease or end-stage renal disease.

  2016cites this paper
• Role of suPAR and Lactic Acid in Diagnosing Sepsis and Predicting Mortality in Elderly Patients

  2016cites this paper
• Development and Validation of a Fluorescent Multiplexed Immunoassay for Measurement of Transgenic Proteins in Cotton (Gossypium hirsutum).

  2016cites this paper
• Review of Ten Biomarkers of Coronary Artery Diseases

  2016cites this paper
• Plasma suPAR is lowered by smoking cessation: a randomized controlled study

  2016cites this paper
• Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters

  2015cites this paper
• suPAR: The unspecific marker for disease presence, severity and prognosis.

  2015cites this paper
• Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years

  2015cites this paper
• Soluble urokinase plasminogen activator receptor--a valuable biomarker in systemic lupus erythematosus?

  2015cites this paper
• The Inflammatory Marker suPAR After Cardiac Arrest

  2015cites this paper
• Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

  2015cites this paper
• soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

  2015cites this paper
• soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

  2015cites this paper
• soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

  2015cites this paper
• Soluble urokinase plasminogen activator receptor and incidence of venous thromboembolism

  2015cites this paper
• Antibody arrays in biomarker discovery.

  2015cites this paper
• Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department

  2015cites this paper
• Analysis of septic biomarker patterns: prognostic value in predicting septic state.

  2015cites this paper
• Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD

  2015cites this paper
• Soluble Urokinase Plasminogen Activator Receptor : exploring its potential as a marker of cardiovascular disease development in black South Africans of the PURE study

  2015cites this paper
• Development of a bead-based aptamer/antibody detection system for C-reactive protein.

  2015cites this paper
• Plaque and blood vulnerability in ST segment elevation myocardial infarction patients: association between lesion morphology using intravascular ultrasound radiofrequency analysis and circulating biomarkers

  2014cites this paper
• Soluble urokinase-type plasminogen activator receptor as a prognostic biomarker in critically ill patients.

  2014cites this paper
• Editorial Comment from Dr Hanno to Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis

  2014cites this paper
• Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events

  2014cites this paper
• The maternal and fetal inflammatory response in normal pregnancy and fetal growth restriction: An ultrasound, flow-cytometry and immunoassay study

  2014cites this paper
• Protein expression profiling by antibody array analysis with use of dried blood spot samples on filter paper.

  2014cites this paper
• Potential urine and serum biomarkers for patients with bladder pain syndrome/interstitial cystitis

  2014cites this paper
• Soluble Urokinase Plasminogen Activator Receptor: A Risk Factor for Carotid Plaque, Stroke, and Coronary Artery Disease

  2014cites this paper
• A Double-Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) versus Oral Oxybutynin in SCI Patients with NDO (11-09-10-04)

  2014cites this paper
• Diagnostic and prognostic significance of suPAR in traumatic brain injury.

  2014cites this paper
• Risk Factor for Carotid Plaque , Stroke , and Coronary Artery Disease

  2013cites this paper
• Soluble urokinase plasminogen activator receptor for risk prediction in patients admitted with acute chest pain.

  2013cites this paper
• Performance of Multiplex Cytokine Assays in Serum and Saliva among Community-Dwelling Postmenopausal Women

  2013cites this paper
• Potential urine and serum biomarkers for patients with overactive bladder and interstitial cystitis/bladder pain syndrome

  2013cites this paper
• Infectious Disease Biomarkers: Non-Antibody-Based Host Responses

  2013cites this paper
• Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia

  2012cites this paper
• Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

  2012influential citation
• Safety and Tolerability of Lactobacillus reuteri DSM 17938 and Effects on Biomarkers in Healthy Adults: Results from a Randomized Masked Trial

  2012cites this paper
• Soluble urokinase plasminogen activator receptor in plasma is associated with incidence of CVD. Results from the Malmö Diet and Cancer Study.

  2012cites this paper
• Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor

  2012cites this paper
• Optimization and qualification of a multiplex bead array to assess cytokine and chemokine production by vaccine-specific cells.

  2012influential citation
• Inflammation in HIV-Infected Patients: Impact of HIV, Lifestyle, Body Composition, and Demography – A Cross Sectional Cohort Study

  2012cites this paper
• Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study

  2011cites this paper
• Multisite Comparison of High-Sensitivity Multiplex Cytokine Assays

  2011cites this paper
• The TGF-ß/SMAD signalling system and extracellular matrix changes in myocardial remodelling and reverse remodelling following correction of pressure overload

  2011cites this paper
• Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

  2011cites this paper
• Department of Cardiothoracic Surgery

  2011cites this paper
• Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis.

  2011cites this paper